Nearly one-third of childhood schizophrenia diagnoses may be mistaken, study reveals

A recent study at the NIH highlights the challenges of diagnosing childhood-onset schizophrenia, revealing that nearly a third of suspected cases are misdiagnosed, underscoring the importance of careful observation and flexible assessment.

In nearly two decades at the National Institute of Mental Health, Nitin Gogtay worked on one of the world’s largest studies of childhood-onset schizophrenia, a rare and severe diagnosis that often brings families to Bethesda after months or years of uncertainty. In a recent essay, Gogtay said the study’s most unsettling finding was not how often the illness was confirmed, but how often it was not: almost a third of the children admitted with a suspected diagnosis did not actually have schizophrenia.

That finding fits with what psychiatry specialists have long said about the disorder in children. Psychiatric Times has noted that childhood-onset schizophrenia is difficult to diagnose because its early signs can overlap with language delays, autism-spectrum traits, attention-deficit hyperactivity disorder, depression, anxiety and obsessive-compulsive symptoms. The distinction between fixed psychosis and severe fear or intrusive thoughts can be especially hard to draw in younger patients.

Gogtay’s account also underlines the limits of routine outpatient care. According to Psychiatric Times and a review in the National Library of Medicine, outpatient screening in one study identified the illness correctly in just 55 per cent of cases, while inpatient observation, including time off medication, helped rule out alternative diagnoses in 96 children who had been provisionally admitted. The review said that standard clinical ratings missed many of the non-schizophrenia cases, reinforcing the value of careful observation when the picture is unclear.

At the NIH, that longer observation period mattered. Gogtay said the team had time to watch children over days and weeks, and, when appropriate, to withdraw medications under supervision. In many cases, the symptoms that had been treated as psychosis either faded or pointed to another explanation, including severe anxiety, trauma, depression or OCD. One boy described in the essay was eventually found to be frightened and severely obsessive-compulsive, with the “voices” he reported reflecting his own fearful inner speech rather than schizophrenia.

The broader warning is not limited to psychiatry. A diagnosis can harden into fact once treatment starts, even when the original label was only a working hypothesis. Gogtay argues that child psychiatry is especially vulnerable because there is no blood test, scan or biopsy that can confirm the condition. In that setting, time itself becomes the most useful diagnostic tool, and the most responsible answer is sometimes to keep asking questions rather than rush to certainty.

For families, that can mean a frustrating delay. For clinicians, it means resisting the urge to close the case too soon. Gogtay’s conclusion is blunt: if a diagnosis has not yet earned its permanence, it should be revisited. In a field where a wrong label can shape a child’s treatment, identity and future, he argues that the discipline to pause may be more important than the confidence to decide quickly.